BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Pharm Country

  NeoStem, Inc. to Present at Multiple Conferences in October

  October 2, 2012

   · 

  1 min read
• Drug Development

  Provectus Pharmaceuticals Inc. Presents Final Phase 2 Melanoma Data at ESMO 2012

  October 2, 2012

   · 

  1 min read
• Drug Development

  Athersys, Inc. Reports on Progress in Phase 2 Study of MultiStem for Ischemic Stroke

  October 2, 2012

   · 

  1 min read
• Biotech Bay

  Astex Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) Investor Forum

  October 2, 2012

   · 

  1 min read
• Policy

  Allergan Inc. Comments on Order Regarding Permanent Injunction Against Merz Pharmaceuticals, LLC and Merz Aesthetics (Formerly Known as BioForm Medical, Inc.)

  October 2, 2012

   · 

  1 min read
• Business

  Biosensors International Extends Licensing Agreement With Terumo Corporation to Sell BioMatrix Technology Globally

  October 2, 2012

   · 

  3 min read
• BioMidwest

  Biomet Inc. Completes $825,000,000 Senior Notes Offering and $800,000,000 Senior Subordinated Notes Offering

  October 2, 2012

   · 

  1 min read
• Business

  Tolera Therapeutics, Inc. Announces Appointment of Linda C. Hogan as Vice President, Business Development

  October 2, 2012

   · 

  2 min read
• Business

  Furiex Pharmaceuticals, Inc. Announces Third Quarter 2012 Earnings Release and Conference Call

  October 2, 2012

   · 

  1 min read
• Drug Development

  Noven Pharmaceuticals Inc. Announces Commencement of Phase 2 Study of Investigational d-Amphetamine Transdermal System for ADHD

  October 2, 2012

   · 

  1 min read